Bastianutto C - Search Results

1

Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen.

Yip KW, Mao X, Au PY, Hedley DW, Chow S, Dalili S, Mocanu JD, Bastianutto C, Schimmer A, Liu FF. Yip KW, et al. Among authors: bastianutto c. Clin Cancer Res. 2006 Sep 15;12(18):5557-69. doi: 10.1158/1078-0432.CCR-06-0536. Clin Cancer Res. 2006. PMID: 17000693

2

Potential use of cetrimonium bromide as an apoptosis-promoting anticancer agent for head and neck cancer.

Ito E, Yip KW, Katz D, Fonseca SB, Hedley DW, Chow S, Xu GW, Wood TE, Bastianutto C, Schimmer AD, Kelley SO, Liu FF. Ito E, et al. Among authors: bastianutto c. Mol Pharmacol. 2009 Nov;76(5):969-83. doi: 10.1124/mol.109.055277. Epub 2009 Aug 4. Mol Pharmacol. 2009. PMID: 19654225

3

Combination bcl-2 antisense and radiation therapy for nasopharyngeal cancer.

Yip KW, Mocanu JD, Au PY, Sleep GT, Huang D, Busson P, Yeh WC, Gilbert R, O'Sullivan B, Gullane P, Bastianutto C, Liu FF. Yip KW, et al. Among authors: bastianutto c. Clin Cancer Res. 2005 Nov 15;11(22):8131-44. doi: 10.1158/1078-0432.CCR-05-1266. Clin Cancer Res. 2005. PMID: 16299246

4

Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent.

Yip KW, Ito E, Mao X, Au PY, Hedley DW, Mocanu JD, Bastianutto C, Schimmer A, Liu FF. Yip KW, et al. Among authors: bastianutto c. Mol Cancer Ther. 2006 Sep;5(9):2234-40. doi: 10.1158/1535-7163.MCT-06-0134. Mol Cancer Ther. 2006. PMID: 16985057

5

Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.

Yip KW, Shi W, Pintilie M, Martin JD, Mocanu JD, Wong D, MacMillan C, Gullane P, O'Sullivan B, Bastianutto C, Liu FF. Yip KW, et al. Among authors: bastianutto c. Clin Cancer Res. 2006 Oct 1;12(19):5726-32. doi: 10.1158/1078-0432.CCR-06-0571. Clin Cancer Res. 2006. PMID: 17020977

6

Imaging and modulating antisense microdistribution in solid human xenograft tumor models.

Mocanu JD, Yip KW, Skliarenko J, Shi W, Busson P, Lo KW, Bastianutto C, Liu FF. Mocanu JD, et al. Among authors: bastianutto c. Clin Cancer Res. 2007 Oct 1;13(19):5935-41. doi: 10.1158/1078-0432.CCR-06-3085. Clin Cancer Res. 2007. PMID: 17908990

7

Combined in vivo bioluminescence and fluorescence imaging for cancer gene therapy.

Mocanu JD, Moriyama EH, Chia MC, Li JH, Yip KW, Huang DP, Bastianutto C, Wilson BC, Liu FF. Mocanu JD, et al. Among authors: bastianutto c. Mol Imaging. 2004 Oct;3(4):352-5. doi: 10.1162/15353500200404157. Mol Imaging. 2004. PMID: 15802052

8

Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.

Chia MC, Leung A, Krushel T, Alajez NM, Lo KW, Busson P, Klamut HJ, Bastianutto C, Liu FF. Chia MC, et al. Among authors: bastianutto c. Clin Cancer Res. 2008 Feb 15;14(4):984-94. doi: 10.1158/1078-0432.CCR-07-0828. Clin Cancer Res. 2008. PMID: 18281530

9

Increased efficiency for performing colony formation assays in 96-well plates: novel applications to combination therapies and high-throughput screening.

Katz D, Ito E, Lau KS, Mocanu JD, Bastianutto C, Schimmer AD, Liu FF. Katz D, et al. Among authors: bastianutto c. Biotechniques. 2008 Feb;44(2):ix-xiv. doi: 10.2144/000112757. Biotechniques. 2008. PMID: 18422490 Free article.

10

Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer.

Shi W, Alajez NM, Bastianutto C, Hui AB, Mocanu JD, Ito E, Busson P, Lo KW, Ng R, Waldron J, O'Sullivan B, Liu FF. Shi W, et al. Among authors: bastianutto c. Int J Cancer. 2010 May 1;126(9):2036-48. doi: 10.1002/ijc.24880. Int J Cancer. 2010. PMID: 19739117

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters